Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

1 The present invention provides compounds of Formula (I): wherein A, B, C, G, and Whave any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Edmunds, Jeremy John
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Edmunds, Jeremy John
description	1 The present invention provides compounds of Formula (I): wherein A, B, C, G, and Whave any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.
format	Patent
fullrecord	<record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07407972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07407972</sourcerecordid><originalsourceid>FETCH-uspatents_grants_074079723</originalsourceid><addsrcrecordid>eNqNykEKAjEMQNFuXIh6h1xAGFQorkXRvYg7iW06UyjJ0GTm_FbwAK7-W_yle9x4yO9sUhUkQcLQCE8E5AhiA1VQqpkJxipGqKSQeZYyU2yAdkAQ7KeCloUhoAaMtHaLhEVp8-vKweV8P123k45oxKavvuI3nT90_uh3-z-WD8HDOmU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade</title><source>USPTO Issued Patents</source><creator>Edmunds, Jeremy John</creator><creatorcontrib>Edmunds, Jeremy John ; Pfizer Inc</creatorcontrib><description>1 The present invention provides compounds of Formula (I): wherein A, B, C, G, and Whave any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7407972$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,309,781,803,886,64044</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7407972$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Edmunds, Jeremy John</creatorcontrib><creatorcontrib>Pfizer Inc</creatorcontrib><title>Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade</title><description>1 The present invention provides compounds of Formula (I): wherein A, B, C, G, and Whave any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNykEKAjEMQNFuXIh6h1xAGFQorkXRvYg7iW06UyjJ0GTm_FbwAK7-W_yle9x4yO9sUhUkQcLQCE8E5AhiA1VQqpkJxipGqKSQeZYyU2yAdkAQ7KeCloUhoAaMtHaLhEVp8-vKweV8P123k45oxKavvuI3nT90_uh3-z-WD8HDOmU</recordid><startdate>20080805</startdate><enddate>20080805</enddate><creator>Edmunds, Jeremy John</creator><scope>EFH</scope></search><sort><creationdate>20080805</creationdate><title>Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade</title><author>Edmunds, Jeremy John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_074079723</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Edmunds, Jeremy John</creatorcontrib><creatorcontrib>Pfizer Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Edmunds, Jeremy John</au><aucorp>Pfizer Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade</title><date>2008-08-05</date><risdate>2008</risdate><abstract>1 The present invention provides compounds of Formula (I): wherein A, B, C, G, and Whave any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_uspatents_grants_07407972
source	USPTO Issued Patents
title	Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T21%3A23%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Edmunds,%20Jeremy%20John&rft.aucorp=Pfizer%20Inc&rft.date=2008-08-05&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07407972%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true